Edap Tms (NASDAQ:EDAP) used its 2026 FocalTherics Investor Day to outline its shift toward becoming a “high-growth, pure-play ...

One in eight men will develop prostate cancer in their lifetime. Surgery to treat the disease can lead to unwelcome side effects. A minimally invasive alternative that avoids surgery is now available ...

CLEVELAND, Ohio (Ivanhoe Newswire) - After skin cancer, prostate cancer is the most common cancer in men in the US. For the men who have beat prostate cancer once, 20 to 30 percent will show signs of ...

One of the most common concerns about treating prostate cancer is preserving sexual function and urinary control. For some prostate cancers, newer treatments offering an alternative to radiation and ...

SAN ANTONIO -- A comparison of high-intensity focused ultrasound (HIFU) and radical prostatectomy (RP) found that HIFU was non-inferior to surgery as primary treatment for localized prostate cancer, ...

High pre-treatment PSA levels correlate with increased recurrence and treatment failure in intermediate-risk prostate cancer patients treated with HIFU. Gleason grade 3 or higher is associated with ...

Focal therapy, including HIFU, targets only cancerous prostate areas, preserving organ function and minimizing side effects like erectile dysfunction and urinary incontinence. HIFU is suitable for ...

High-intensity focused ultrasound (HIFU) is a potentially effective treatment of localized prostate cancer (PCa) that is associated with a low PCa-specific mortality rate, according to researchers. It ...

EUR 62.4 million for 2025, down 3% due to a 27% decline in noncore Distribution and ESWL segments that offset HIFU gains. Q4 ...

Investigators who conducted 2 clinical trials concluded that focal therapy is not inferior to radical prostatectomy with respect to treatment failure. Focal therapy such as high-intensity focused ...